Oriza Seed Leads $25M Round In Chinese Healthcare Company EpimAb Biotherapeutics
April 25, 2017 — 12:00 CST
This Data Is Locked!
This area is available only to Subscribers.
Oriza Seed Venture Capital, an early stage investment unit under Oriza Holdings, has led a US$25 million series A round in EpimAb Biotherapeutics, a Shanghai-based... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals